Phage nanoparticle as a carrier for controlling fungal infection
- PMID: 35501488
- DOI: 10.1007/s00253-022-11932-z
Phage nanoparticle as a carrier for controlling fungal infection
Abstract
A mass of nanocarriers have been exploited and utilized for prevention of fungi, including organic nanomaterials, inorganic nanoparticles, polypeptides, and viruses. Due to biological safety and flexible genetic engineering property, bacteriophages, as bionanoparticles, are widely used in the diagnosis and treatment of microorganisms, which can be easily loaded with proteins and drugs. In particular, random DNAs can be inserted into the genome of phage by phage display technology, and it is possible to obtain the peptide/antibody targeting fungi from phage library. Meanwhile, phages displaying specific peptides are able to conjugate with other nanoparticles, which have both characteristics of peptides and nanomaterials, and have been used for precise detection of fungi. Additionally, phage nanomaterials as carriers can reduce the toxicity of drugs, increase the time of drug circulation, stimulate the immune response, and have an anti-fungal effect by itself. In this review, we summarize the recent applications of bacteriophages on the study of fungi. The improvement of our understanding of bacteriophage will supply new tools for controlling fungal infections. These phage libraries were used to pan the specific peptides for diagnosis, prevention, and treatment of fungi. KEY POINTS: • System fungal infection has no significant clinical symptoms; it is important to develop vaccine, diagnosis, and therapeutic agents to reduce mortality; phage is an ideal carrier for vaccine and drug to stimulate immune response and improve the efficiency of drug, and also can improve the sensitivity of detection • This review summarized recent studies on phage-based fungal vaccine and threw light on the developing therapeutic phage in the treatment of fungal infection.
Keywords: Fungi; Nanoparticle; Phage; Therapy; Vaccine; Vector.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.Drug Deliv. 2017 Nov;24(1):1898-1908. doi: 10.1080/10717544.2017.1410259. Drug Deliv. 2017. PMID: 29191048 Free PMC article. Review.
-
Evolution of phage display technology: from discovery to application.J Drug Target. 2017 Mar;25(3):216-224. doi: 10.1080/1061186X.2016.1258570. Epub 2016 Nov 21. J Drug Target. 2017. PMID: 27819143 Review.
-
Phage as a Genetically Modifiable Supramacromolecule in Chemistry, Materials and Medicine.Acc Chem Res. 2016 Jun 21;49(6):1111-20. doi: 10.1021/acs.accounts.5b00557. Epub 2016 May 6. Acc Chem Res. 2016. PMID: 27153341 Free PMC article.
-
Phage Display-Selected Peptides: Research and Clinical Applications in Cancer Imaging.J Pept Sci. 2025 Jul;31(7):e70034. doi: 10.1002/psc.70034. J Pept Sci. 2025. PMID: 40460842 Review.
-
Bacteriophages and medical oncology: targeted gene therapy of cancer.Med Oncol. 2014 Aug;31(8):110. doi: 10.1007/s12032-014-0110-9. Epub 2014 Jul 11. Med Oncol. 2014. PMID: 25012686 Review.
Cited by
-
Nanoparticle-based antifungal therapies innovations mechanisms and future prospects.PeerJ. 2025 Apr 8;13:e19199. doi: 10.7717/peerj.19199. eCollection 2025. PeerJ. 2025. PMID: 40226540 Free PMC article. Review.
-
Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders.Pharmaceuticals (Basel). 2023 Jan 10;16(1):96. doi: 10.3390/ph16010096. Pharmaceuticals (Basel). 2023. PMID: 36678597 Free PMC article. Review.
References
-
- Aghebati-Maleki L, Bakhshinejad B, Baradaran B, Motallebnezhad M, Aghebati-Maleki A, Nickho H, Yousefi M, Majidi J (2016) Phage display as a promising approach for vaccine development. J Biomed Sci 23:66 - DOI
-
- Anandakumar S, Boosi KN, Bugatha H, Padmanabhan B, Sadhale PP (2011) Phage displayed short peptides against cells of Candida albicans demonstrate presence of species, morphology and region specific carbohydrate epitopes. PloS One 6:e16868 - DOI
-
- Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–1122 - DOI
-
- Bazan J, Całkosiński I, Gamian A (2012) Phage display-a powerful technique for immunotherapy: 2. Vaccine delivery. Hum Vaccin Immunother 8:1829–1835 - DOI
-
- Casjens SR, Hendrix RW (2015) Bacteriophage lambda: early pioneer and still relevant. Virology 479–480:310–330 - DOI
Publication types
MeSH terms
Substances
Grants and funding
- 81901880/Innovative Research Group Project of the National Natural Science Foundation of China
- 20200201505JC/Natural Science Foundation of Jilin Province
- 20190103099JH/Natural Science Foundation of Jilin Province
- JJKH20201016KJ/Education Department of Jilin Province
- 2019SRCJ003/Department of Finance of Jilin Province
LinkOut - more resources
Full Text Sources
Medical